Talk:Antiphospholipid syndrome

Medicine: Neurology B‑class Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
B	This article has been rated as B-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Neurology task force (assessed as Mid-importance).

The suggestion is made in this article that the anti phospholipid syndrome is caused by auto antibodies directed against negatively charged phospholipids on the cell/platelet surface. However for almost 15 years it is known that most of the antibodies in this syndrome are directed against proteins that bind negatively charged phospholipids such as prothrombin and beta-2-glycoprotein-1. It is the binding of antibodies to coagulation proteins that causes altered coagulation processes not the binding of antibodies against negatively charged phospholipids.

I suggest to change the article to correct this misunderstanding. Bio2mancer 24 june 2006.

{{sofixit}} JFW | T@lk 20:58, 4 July 2006 (UTC)[reply]

Sapporo criteria

We should mention the Sapporo criteria: PMID 10403256 . JFW | T@lk 20:58, 4 July 2006 (UTC)[reply]

And a recent amendment: PMID 16420554 . JFW | T@lk 20:59, 4 July 2006 (UTC)[reply]

Recent review

A recent systematic review on the treatment shows how little we actually know about optimal treatment for this: PMID 16507806. JFW | T@lk 21:01, 4 July 2006 (UTC)[reply]

Furthermore, a new study in the New England Journal of Medicine -- Kaandorp SP et al, N Engl J Med 362;17p1586–1596 shows no benefit of aspirin + LMWH over placebo -- in women with recurrent miscarriage -- and the accompanying editorial states that although inherited thrombophilia is associated with miscarriage, anticoagulants in this indication don't help. We know less than we think!

Page has massive changes

Since 07 NOV 06...actually making this page very inaccurate. Please revert back to previous revision before 07 NOV 06. Tried to get the categories back in. Hopefully I did it right.eyz 00:10, 21 November 2006 (UTC)

Typo

Changed a typo (phosphotidylserine to Phosphatidylserine). Rage italic 15:54, 30 March 2007 (UTC)[reply]

APSFA Page

Actaully that page is cited and is HONCode certifed. Very few sites can say that. It has a bio. upon request.eyz 17:53, 20 May 2007 (UTC)

APSCORE

APSCORE is no longer functioning due to lack of funding from the CDC and NIH. Link Removed. eyz

Nature of antibodies

Some antibodies are more aborto/thrombogenic than others PMID 17440049 JFW | T@lk 06:42, 7 August 2007 (UTC)[reply]

Blood!

doi:10.1182/blood-2007-12-129627 - how we diagnose APS. JFW | T@lk 17:29, 1 February 2009 (UTC)[reply]

Sentence

Hi. In the section under the subsubhead 2.1, Lupus anticoagulant, we currently begin the second paragraph thus: "Distinguishing a lupus antibody from a specific coagulation factor inhibitor (eg: Factor VIII)." This is not a sentence and does not make sense on its own. I'd fix it if I was sure how to without distorting the intended sense, but I'm not. (I was tempted to weld it into the next sentence but I'm not 100% certain that works - or was it like a yet another subhead perhaps??) Can someone who can see the sense of the whole thing please sort it out? Thanks and best wishes, DBaK (talk) 11:21, 20 November 2009 (UTC)[reply]

Source

Is House MD a reliable and authentic source?